Information om | Engelska ordet TRANSAMINASES

Exempel på hur man kan använda TRANSAMINASES i en mening

• Immunoaffinity media (detailed below) utilizes antigens' and antibodies' high specificity to separate; immobilized metal affinity chromatography is detailed further below and uses interactions between metal ions and proteins (usually specially tagged) to separate; nucleotide/coenzyme that works to separate dehydrogenases, kinases, and transaminases.
• More than 10% of users develop adverse effects, including difficulty breathing, low white and red blood cells counts, low platelet counts, vomiting and nausea, elevated transaminases, rashes and itchy skin, hair loss, blood and protein in urine, flu-like symptoms, and edema.
• Additionally, amineptine is known to rarely elevate transaminases, alkaline phosphatase, and bilirubin.
• Its administration in rat induces hepatic encephalopathy, metabolic acidosis, increased levels of transaminases, abnormal coagulation, and centrilobular necrosis, which are the main features of the clinical chronic liver disease so thioacetamide can precisely replicate the initiation and progression of human liver disease in an experimental animal model.
• Common side effects include allergic reaction, anemia, neutropenia, elevated transaminases, and pyuria.
• Hepatic Toxicity : Postmarketing reports revealed asymptomatic increases in transaminases (ALT and/or AST), fatty liver degeneration, decompensation of preexisting liver cirrhosis, and acute treatment-related liver failure.
• It is also associated with hormonal disorders (panhypopituitarism, hypothyroidism, hypogonadism, polycystic ovary syndrome), persistently elevated transaminases, increasing age, and hypoxia caused by obstructive sleep apnea; some of these conditions predict disease progression.
• Unwanted side effects include dizziness, reversible cholestatic jaundice, pseudoallergic reaction, and elevated levels of liver enzymes (transaminases and gamma-glutamyltransferase).
• Aminotransferases (transaminases) in general have been used to create unnatural amino acids, important building blocks for peptidomimetic drugs and agricultural products.
• In clinical trials, 18% of subjects taking mipomersen stopped using the drug due to adverse effects; the most common adverse effects leading to discontinuation were injection site reactions, increases of transaminases, flu-like symptoms (fever, chills, abdominal pain, nausea, vomiting), and abnormal liver tests.
• Very common adverse effects (greater than 10% of people) include decreased appetite; low calcium, potassium, phosphate, and magnesium levels; high bilirubin levels; distorted sense of taste, headache, and dizziness; high blood pressure; distorted sense of hearing, earaches and sore throat; diarrhea, nausea, constipation, vomiting, stomach pain and upset stomach, and inflammation of the mouth and lips and a burning sensation in the mouth; skin sloughing off the palms and soles, hair color changes and hair loss, rash, dry skin, and red skin; joint pain and muscle spasms; fatigue and weakness; weight loss, elevated transaminases, higher cholesterol levels, and loss of red and white blood cells.
• The widest range of applications come from ketoreductases and transaminases, but there are isolated examples from hydrolases, aldolases, oxidative enzymes, esterases and dehalogenases, among others.
• Loewy continued his research on Factor XIII, transaminases, and later on isopeptidases and their effects on neurofibrillary tangles, aggregates of tau protein found in Alzheimer's disease and other diseases known as tauopathies.
• These biocatalysts, which include amine/alcohol oxidases, imine reductases, lyases, transaminases and monooxygenases, are then applied to the synthesis of a range of target molecules especially pharmaceuticals and fine chemicals.
• From the digestive system: gastralgia, diarrhea or constipation, increased activity of "hepatic" transaminases, hepatitis (hepatocellular, cholestatic or mixed, with or without jaundice, usually reversible), acute pancreatitis.
• During hospitalization, she developed serious systemic effects, such as intravascular hemolytic anemia evidenced by hyperbilirubinemia, direct bilirubin, low levels of hemoglobin and hematocrit, elevated transaminases, leukocytosis with neutrophilia, creatine kinase increase, metabolic acidosis and hematuria.

Förberedelsen av sidan tog: 127,45 ms.